Favorable outcomes of radiotherapy for early-stage mucosa-associated lymphoid tissue lymphoma

Radiotherapy and Oncology

Volumn 90, Issue 2, 2009, Pages 231-235

  Tomita, Natsuo ^a   Kodaira, Takeshi ^a   Tachibana, Hiroyuki ^a   Nakamura, Tatsuya ^a   Mizoguchi, Nobutaka ^a   Takada, Akinori ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Head and neck; Mucosa associated lymphoid tissue lymphoma; Non Hodgkin's lymphoma; Radiation therapy; Salvage radiation therapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CATARACT; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; CONJUNCTIVITIS; FEMALE; FOLLOW UP; HUMAN; KERATITIS; MALE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; ORBIT TUMOR; OVERALL SURVIVAL; PAROTID GLAND TUMOR; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RADIATION PNEUMONIA; SALVAGE THERAPY; STOMACH TUMOR; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR RECURRENCE; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; LYMPHOMA, B-CELL, MARGINAL ZONE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIATION INJURIES; RADIOTHERAPY DOSAGE; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 59649117869     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.12.004     Document Type: Article

References (31)

1. Armitage J.O., and Weisenburger D.D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's lymphoma classification project. J Clin Oncol 16 (1998) 2780-2795
2. Bayerdorffer E., Neubauer A., Rudolph B., et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT lymphoma study group. Lancet 345 (1995) 1591-1594
3. Conconi A., Martinelli G., Thieblemont C., et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 102 (2003) 2741-2745
4. Dijkema T., Terhaard C.H., Roesink J.M., et al. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated VERSUS conventional radiotherapy. Int J Radiat Oncol Biol Phys 72 (2008) 1101-1109
5. Drillenburg P., van der Voort R., Koopman G., et al. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. Am J Pathol 150 (1997) 919-927
6. Du X., and Williams D.A. Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89 (1997) 3897-3908
7. Ferreri A.J., Ponzoni M., Guidoboni M., et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 23 (2005) 5067-5073
8. Graziadei G., Pruneri G., Carboni N., et al. Low-grade MALT lymphoma involving multiple mucosal sites and bone marrow. Ann Hematol 76 (1998) 81-83
9. Harris N.L., Jaffe E.S., Stein H., et al. A revised European--American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
10. Harris N.L., Jaffe E.S., Diebold J., et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 17 (1999) 3835-3849
11. Hasegawa M., Kojima M., Shioya M., et al. Treatment results of radiotherapy for malignant lymphoma of the orbit and histopathologic review according to the WHO classification. Int J Radiat Oncol Biol Phys 57 (2003) 172-176
12. Isobe K., Kagami Y., Higuchi K., et al. A multicenter phase II study of local radiation therapy for stage IEA mucosa-associated lymphoid tissue lymphomas: a preliminary report from the Japan Radiation Oncology Group (JAROG). Int J Radiat Oncol Biol Phys 69 (2007) 1181-1186
13. Jager G., Neumeister P., Brezinschek R., et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 20 (2002) 3872-3877
14. Nakamura S., Matsumoto T., Ye H., et al. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a clinicopathologic and molecular study with reference to antibiotic treatment. Cancer 107 (2006) 2770-2778
15. Le Q.T., Eulau S.M., George T.I., et al. Primary radiotherapy for localized orbital MALT lymphoma. Int J Radiat Oncol Biol Phys 52 (2002) 657-663
16. Liao Z., Ha C.S., McLaughlin P., et al. Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmatic presentation: natural history and patterns of disease progression. Int J Radiat Oncol Biol Phys 48 (2000) 399-403
17. Olivier K.R., Brown P.D., Stafford S.L., Ansell S.M., and Martenson Jr. J.A. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. Int J Radiat Oncol Biol Phys 60 (2004) 1510-1514
18. Pfeffer M.R., Rabin T., Tsvang L., Goffman J., Rosen N., and Symon Z. Orbital lymphoma: is it necessary to treat the entire orbit?. Int J Radiat Oncol Biol Phys 60 (2004) 527-530
19. Raderer M., Wohrer S., Streubel B., et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 24 (2006) 3136-3141
20. Stafford S.L., Kozelsky T.F., Garrity J.A., et al. Orbital lymphoma: radiotherapy outcome and complications. Radiother Oncol 59 (2001) 139-144
21. Suh C., Huh J., and Roh J.L. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue arising in the extracranial head and neck region: a high rate of dissemination and disease recurrence. Oral Oncol 44 (2008) 949-955
22. Suh C.O., Shim S.J., Lee S.W., Yang W.I., Lee S.Y., and Hahn J.S. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior. Int J Radiat Oncol Biol Phys 65 (2006) 228-233
23. Tanimoto K., Kaneko A., Suzuki S., et al. Primary ocular adnexal MALT lymphoma: a long-term follow-up study of 114 patients. Jpn J Clin Oncol 37 (2007) 337-344
24. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-18.
25. Thieblemont C., Bastion Y., Berger F., et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 15 (1997) 1624-1630
26. Thieblemont C., Berger F., Dumontet C., et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 95 (2000) 802-806
27. Tsang R.W., Gospodarowicz M.K., Pintilie M., et al. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome. J Clin Oncol 21 (2003) 4157-4164
28. Tsang R.W., Gospodarowicz M.K., Pintilie M., et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 1258-1264
29. Wenzel C., Fiebiger W., Dieckmann K., Formanek M., Chott A., and Raderer M. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue of the head and neck area: high rate of disease recurrence following local therapy. Cancer 97 (2003) 2236-2241
30. Yamashita H., Nakagawa K., Asari T., Murakami N., Igaki H., and Ohtomo K. Radiotherapy for 41 patients with stages I and II MALT lymphoma: a retrospective study. Radiother Oncol 87 (2008) 412-417
31. Zinzani P.L., Stefoni V., Musuraca G., et al. Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer 100 (2004) 2190-2194